Senate Bill No. introduced by K. Bogner revises the Right to Try Act by amending Section 50-12-104 of the Montana Code Annotated. The bill establishes specific eligibility requirements for patients seeking treatment with investigational drugs, biological products, or devices. These requirements include having considered all other FDA-approved treatment options, receiving a recommendation from a treating healthcare provider, providing written informed consent, and obtaining documentation from the provider confirming eligibility.

A significant change introduced in this bill is the limitation on the treatment of minors. The new language specifies that a minor is not eligible for treatment with an investigational drug, biological product, or device unless they have a terminal illness, which must be attested to by the minor's treating healthcare provider. This amendment aims to ensure that only minors with terminal conditions can access investigational treatments, thereby tightening the criteria for such cases.

Statutes affected:
LC Text: 50-12-104
SB0353_1(1): 50-12-104
SB0353_1(2): 50-12-104
SB0353_1(3): 50-12-104
SB0353_1: 50-12-104